Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Shapiro

Showing results (251-260 of 324) with videos related to

Pageof 33
Sort By:
European Journal of Heart Failure|September 22, 2025
Effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular-kidney-metabolic comorbidityTariq Jamal Siddiqi, Muhammad Shahzeb Khan, Saad Ahmed Waqas, et al.
Circulation. Heart Failure|January 26, 2022
Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018Abdul Mannan Khan Minhas, Sardar Hassan Ijaz, Shakeel Jamal, et al.
Progress in Cardiovascular Diseases|May 22, 2026
Comparative associations of LDL-C, Lp(a), hsCRP, and IL-6 with cardiovascular risk: Insights from the United Kingdom (UK) biobank and the multi-ethnic study of atherosclerosis (MESA)James McParland, Rishi Rikhi, Harpreet S Bhatia, et al.
Journal of the American Heart Association|February 11, 2026
Lipoprotein(a), Insulin Resistance, and Cardiovascular Disease in the UK BiobankRichard Kazibwe, Christopher L Schaich, Parag A Chevli, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Closing the Gaps in Care of Dyslipidemia: Revolutionizing Management with Digital Health and Innovative Care ModelsSamuel J Apple, Rachel Clark, Jonathan Daich, et al.
American Journal of Preventive Cardiology|August 25, 2020
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive CardiologyAmit Khera, Seth J Baum, Ty J Gluckman, et al.
American Journal of Preventive Cardiology|December 17, 2025
Evolving strategies in cardiovascular disease prevention: 2025 American society for preventive cardiology highlightsAnnalisa Filtz, Michael D Shapiro, Paul K Whelton, et al.
Journal of the American Heart Association|March 17, 2023
Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular EventsIsaac Acquah, Kobina Hagan, Zulqarnain Javed, et al.
Functional Ecology|September 20, 2023
Toxin tolerance across landscapes: Ecological exposure not a prerequisiteM Denise Dearing, Teri J Orr, Dylan M Klure, et al.
Atherosclerosis|June 27, 2022
Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary preventionAbdulhamied Alfaddagh, Karan Kapoor, Zeina A Dardari, et al.
Pageof 33

Showing results (251-260 of 324) with videos related to

Sort By:
Pageof 33
European Journal of Heart Failure|September 22, 2025
Effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular-kidney-metabolic comorbidityTariq Jamal Siddiqi, Muhammad Shahzeb Khan, Saad Ahmed Waqas, et al.
Circulation. Heart Failure|January 26, 2022
Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018Abdul Mannan Khan Minhas, Sardar Hassan Ijaz, Shakeel Jamal, et al.
Progress in Cardiovascular Diseases|May 22, 2026
Comparative associations of LDL-C, Lp(a), hsCRP, and IL-6 with cardiovascular risk: Insights from the United Kingdom (UK) biobank and the multi-ethnic study of atherosclerosis (MESA)James McParland, Rishi Rikhi, Harpreet S Bhatia, et al.
Journal of the American Heart Association|February 11, 2026
Lipoprotein(a), Insulin Resistance, and Cardiovascular Disease in the UK BiobankRichard Kazibwe, Christopher L Schaich, Parag A Chevli, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Closing the Gaps in Care of Dyslipidemia: Revolutionizing Management with Digital Health and Innovative Care ModelsSamuel J Apple, Rachel Clark, Jonathan Daich, et al.
American Journal of Preventive Cardiology|August 25, 2020
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive CardiologyAmit Khera, Seth J Baum, Ty J Gluckman, et al.
American Journal of Preventive Cardiology|December 17, 2025
Evolving strategies in cardiovascular disease prevention: 2025 American society for preventive cardiology highlightsAnnalisa Filtz, Michael D Shapiro, Paul K Whelton, et al.
Journal of the American Heart Association|March 17, 2023
Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular EventsIsaac Acquah, Kobina Hagan, Zulqarnain Javed, et al.
Functional Ecology|September 20, 2023
Toxin tolerance across landscapes: Ecological exposure not a prerequisiteM Denise Dearing, Teri J Orr, Dylan M Klure, et al.
Atherosclerosis|June 27, 2022
Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary preventionAbdulhamied Alfaddagh, Karan Kapoor, Zeina A Dardari, et al.
Pageof 33